Safety of rivaroxaban (Xarelto®) in patients with atrial fibrillation (AF) in the drug's early uptake period and to assess Sentinel's active-surveillance system.
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions
- 19 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management